<p>GADD45α-targeted suicide gene therapy driven by synthetic CArG promoter E9NS sensitizes NSCLC cells to cisplatin, resveratrol, and radiation regardless of p53 status</p>

Qiwen Shi(Zhejiang University of Technology), Deepak Bhatia(Shenandoah University)
OncoTargets and Therapy
April 1, 2019
Cited by 6


Related Papers